Clementine Karageorgiou

1.7k total citations · 1 hit paper
24 papers, 1.1k citations indexed

About

Clementine Karageorgiou is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Clementine Karageorgiou has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Clementine Karageorgiou's work include Polyomavirus and related diseases (6 papers), Multiple Sclerosis Research Studies (5 papers) and Dementia and Cognitive Impairment Research (5 papers). Clementine Karageorgiou is often cited by papers focused on Polyomavirus and related diseases (6 papers), Multiple Sclerosis Research Studies (5 papers) and Dementia and Cognitive Impairment Research (5 papers). Clementine Karageorgiou collaborates with scholars based in Greece, United States and Belgium. Clementine Karageorgiou's co-authors include Tamir Ben‐Hur, Ibrahim Kassis, Dimitrios Karussis, Panayiota Petrou, Jeff W. M. Bulte, Adi Vaknin‐Dembinsky, Shimon Slavin, Oded Abramsky, John M. Gomori and Alexandra Economou and has published in prestigious journals such as Neurology, Free Radical Biology and Medicine and Journal of the Neurological Sciences.

In The Last Decade

Clementine Karageorgiou

24 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis

2010 709 citations Dimitrios Karussis, Clementine Karageorgiou et al. Archives of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clementine Karageorgiou Greece	13	511	310	263	181	155	24	1.1k
Shinichi Oka Japan	20	368 0.7×	347 1.1×	149 0.6×	141 0.8×	188 1.2×	59	1.0k
Peter Connick United Kingdom	15	351 0.7×	253 0.8×	145 0.6×	171 0.9×	81 0.5×	33	972
Yihua An China	18	659 1.3×	445 1.4×	126 0.5×	232 1.3×	297 1.9×	43	1.5k
Aleš Homola Czechia	12	337 0.7×	257 0.8×	122 0.5×	110 0.6×	310 2.0×	12	809
Guilherme Lepski Brazil	18	262 0.5×	216 0.7×	205 0.8×	118 0.7×	300 1.9×	70	1.0k
Panayiota Petrou Israel	17	822 1.6×	515 1.7×	454 1.7×	323 1.8×	224 1.4×	34	1.7k
Gaia Donata Oggioni Italy	11	464 0.9×	279 0.9×	485 1.8×	103 0.6×	187 1.2×	15	832
Ildikó Szalayova United States	13	377 0.7×	343 1.1×	78 0.3×	202 1.1×	198 1.3×	18	962
Tomohisa Furuta Japan	20	240 0.5×	524 1.7×	397 1.5×	116 0.6×	314 2.0×	65	1.3k
Pablo Avalos United States	17	229 0.4×	378 1.2×	284 1.1×	119 0.7×	275 1.8×	31	1.1k

Countries citing papers authored by Clementine Karageorgiou

Since Specialization

Citations

This map shows the geographic impact of Clementine Karageorgiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clementine Karageorgiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clementine Karageorgiou more than expected).

Fields of papers citing papers by Clementine Karageorgiou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clementine Karageorgiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clementine Karageorgiou. The network helps show where Clementine Karageorgiou may publish in the future.

Co-authorship network of co-authors of Clementine Karageorgiou

This figure shows the co-authorship network connecting the top 25 collaborators of Clementine Karageorgiou. A scholar is included among the top collaborators of Clementine Karageorgiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clementine Karageorgiou. Clementine Karageorgiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karageorgiou, Clementine, et al.. (2017). Pregnancy Outcome and Teriflunomide Treatment Exposure for Relapsing Remitting Multiple Sclerosis A 4 year follow up (P1.359). Neurology. 88(16_supplement). 2 indexed citations

Alexoudi, Athanasia, Stavroula Gavrili, Chara Spiliopoulou, et al.. (2016). Possible Implication of GSTP1 and NQO1 Polymorphisms on Natalizumab Response in Multiple Sclerosis.. PubMed. 46(6). 586–591. 14 indexed citations

Alexoudi, Athanasia, et al.. (2014). CombinedGSTP1andNQO1germline polymorphisms in the susceptibility to Multiple Sclerosis. International Journal of Neuroscience. 125(1). 32–37. 12 indexed citations

Verganelakis, Dimitrios, Efstathios D. Gotsis, Panagiotis Toulas, et al.. (2013). Diffusion tensor imaging (DTI) in the detection of white matter lesions in patients with mild cognitive impairment (MCI). Acta Neurologica Belgica. 113(4). 441–451. 18 indexed citations

Paterakis, Georgios, et al.. (2013). Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety. Acta Neurologica Scandinavica. 128(1). e1–e5. 13 indexed citations

Tsiara, Stavroula, et al.. (2013). Paraneoplasmatic encephalitis due to Merkel cell neuroendocrine skin carcinoma. Journal of the Neurological Sciences. 333. e703–e703. 2 indexed citations

Papageorgiou, Eleni, et al.. (2012). JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: A clinico-radiological diagnosis. Clinical Neurology and Neurosurgery. 115(6). 827–829. 3 indexed citations

Zografou, Chrysoula, et al.. (2012). Natalizumab-Associated Progressive Multifocal Leucoencephalopathy: Lessons from Four Different Cases (P07.053). Neurology. 78(Meeting Abstracts 1). P07.053–P07.053. 1 indexed citations

Rankin, Katherine P., Ioannis Tsaousis, John Neuhaus, et al.. (2012). Big 5 Personality Changes in Greek bvFTD, AD, and MCI Patients. Alzheimer Disease & Associated Disorders. 27(3). 258–264. 17 indexed citations

10.

Förstl, Hans, et al.. (2011). Memantine in Everyday Clinical Practice: A Comparison of Studies in Germany and Greece. Dementia and Geriatric Cognitive Disorders. 32(4). 267–272. 7 indexed citations

11.

Alexoudi, Athanasia, et al.. (2011). The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease. Free Radical Biology and Medicine. 51(3). 713–718. 18 indexed citations

12.

Souli, Maria, et al.. (2010). Effects of Antimicrobial Prophylaxis on Asymptomatic Bacteriuria and Predictors of Failure in Patients with Multiple Sclerosis. Journal of Chemotherapy. 22(1). 36–43. 12 indexed citations

13.

Karussis, Dimitrios, Clementine Karageorgiou, Ibrahim Kassis, et al.. (2010). Pilot Phase I/II Clinical Trial with Autologous Mesenchymal Stem Cells in Patients with Multiple Sclerosis and Amyotrophic Lateral Sclerosis. Human Gene Therapy. 21(5). 650. 4 indexed citations

14.

Karussis, Dimitrios, Clementine Karageorgiou, Adi Vaknin‐Dembinsky, et al.. (2010). Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis. Archives of Neurology. 67(10). 1187–94. 709 indexed citations breakdown →

15.

Valotassiou, Varvara, John Papatriantafyllou, Clementine Karageorgiou, et al.. (2009). Evaluation of brain perfusion in specific Brodmann areas in Frontotemporal dementia and Alzheimer disease using automated 3-D voxel based analysis. Journal of Instrumentation. 4(5). P05020–P05020. 6 indexed citations

16.

Kolaitis, Gerasimos, et al.. (2009). Breaking bad news: Communication around parental multiple sclerosis with children.. Families Systems & Health. 27(1). 64–76. 20 indexed citations

17.

Economou, Alexandra, et al.. (2007). Nonepisodic Memory Deficits in Amnestic MCI. Cognitive and Behavioral Neurology. 20(2). 99–106. 57 indexed citations

18.

Manola, Kalliopi N., et al.. (2007). Glutathione‐S‐transferase T1 and M1 gene polymorphisms in Greek patients with multiple sclerosis: a pilot study. European Journal of Neurology. 14(5). 572–574. 22 indexed citations

19.

Vikelis, Michail, John Papatriantafyllou, & Clementine Karageorgiou. (2007). A novel CADASIL-causing mutation in a stroke patient. Swiss Medical Weekly. 137(2122). 323–325. 4 indexed citations

20.

Comı, Gıancarlo, Luisa Roveri, Antony D. Swan, et al.. (2002). A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. Journal of Neurology. 249(10). 1370–1377. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact